Early data on the performance of a combined SARS-CoV-2 spike-nucleocapsid antibody lateral flow immunoassay device compared with a nucleocapsid-only device | Zendy

AI Assistant Blog Pricing

Early data on the performance of a combined SARS-CoV-2 spike-nucleocapsid antibody lateral flow immunoassay device compared with a nucleocapsid-only device

Details

The content you want is available to Zendy users.Already have an account? Click here. to sign in.